Nine Masts Capital »

Ironwood Pharmaceuticals shares owned by Nine Masts Capital

Quarter-by-quarter ownership of Ironwood Pharmaceuticals (IRWD) shares owned by Nine Masts Capital from 13F filings

Historical chart of Nine Masts Capital investment in Ironwood Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ironwood Pharmaceuticals held by Nine Masts Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ironwood Pharmaceuticals by Nine Masts Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $48k 14k 3.51

More positions owned by Nine Masts Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Alphabet Cap Stk Cl C (GOOG)
Warner Bros Discovery Com Ser A (WBD)
Silicon Laboratories (SLAB)
Hdfc Bank Sponsored Ads (HDB)
Electronic Arts (EA)
Fox Corp Cl B Com (FOX)
Norfolk Southern (NSC)
Clearwater Analytics Hldgs I Cl A (CWAN)
Webster Financial Corporation (WBS)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Hologic
Nio Note 4.625%10/1 (Principal)
Ase Technology Hldg Sponsored Ads (ASX)

View all positions for Nine Masts Capital

Top funds holding Ironwood Pharmaceuticals

Vanguard Group
Armistice Capital
BlackRock
UBS Group
Sarissa Capital Management
Bank of America Corporation
Renaissance Technologies
AQR Capital Management
Vanguard Portfolio Management
Acadian Asset Management
Vanguard Capital Management
Two Sigma Investments
Charles Schwab Investment Management
Geode Capital Management
Marshall Wace

View all funds holding Ironwood Pharmaceuticals